Uh Oh – more from the “Danger, danger, Will Robinson!” files – vanden Bossche (mostly) confirms Macmillan’s prognosis that C19 REINFECTION will kill tens of millions over the next few years

A few days ago, I cross posted this:

The Horrific Outcomes of Covid Reinfection (substack.com)

Which featured this video:

The Horrific Outcomes of Covid Reinfection (youtube.com)

“65,057 views Streamed live on Dec 12, 2023 #CovidVaccines #COVID19 #medicine

This information is relevant to everyone, whether vaccinated or not. The risk of covid reinfection is similar across all population groups and needs to be urgently addressed. Bowe, B., Xie, Y. & Al-Aly, Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med 28, 2398–2405 (2022). https://doi.org/10.1038/s41591-022-02... https://www.nature.com/articles/s4159... “”

Note this caveat “Limitations included a cohort of mostly white males.”

Towards the end Dr Macmillan indicated that if we acted in teams, without baggage, there may be a solution to save maybe 60 million lives out of 140 million at extreme risk.

Well, on yesterday’s VSRF weekly, noted vaccinologist/immunologist/virologist Geert vanden Bossche stated that the evolution of the JN1 variant signals a massive reinfection risk to those with the highest doses of C19 injections.

Vanden Bossche differed from Macmillan in saying that the unvaxxed were at low risk, provided they had “trained” their immune system via exposures to all the variants witnessed over the last several years. He also said that prophylaxis with anti-virals (e.g., IVM and HCQ protocols) should start now, before it is too late – sort of “an ounce of prevention, is worth a ton of cure.

Here is a link to his interview with Steve Kirsch on VSRF – skip to 16 minute mark.

VSRF Live #106: Dr. Geert Vanden Bossche on “White Lung” Pneumonia (rumble.com)

Vanden Bossche’s prognosis is an immediate (days/weeks) increase in hospitalisations and deaths maybe ten times worse than what we have seen so far – which would be 70 million deaths, globally.

Here’s an example of his work:

mRNA-based Covid-19 vaccines inevitably lead to genetic, but also immunological disorders! (substack.com)

The JN1 leapt into prominence in the last few weeks.

From here:

CDC COVID Data Tracker: Variant Proportions

Not the top variant yet, but it was not present at end of October 2023.

For context, the “official” records show that, globally, we are about to cross 700 million cases and 7 million deaths since C19 records began.

COVID - Coronavirus Statistics - Worldometer (worldometers.info)

“Cases” (which no longer correlate to tests in that link) for the US) are reported to that website at just a few hundred thousand since end October 2023 – with around 110 million “cases” to date.

It would be great to know how the CDC comes up with its variant proportions. I think it is modelled based on 4 out of 5 or similar US regions.

Ro provide some balance, noted vaxx advocate, Eric Topol, had this to say about JN1, on 5 December 2023.

(100) From a Detour to Global Dominance - by Eric Topol (substack.com)

“Given this anticipated protection of the booster vs JN.1—which was not anticipated—a strong case is made to get a booster, even though to date only 16% of eligible American adults have done so. If you haven’t, this would be a good time to get ready for the wave ahead, especially if you’re in a high-risk group such as advanced age, immunocompromised, or with co-existing conditions.”

There are many treatments from many different specialists, from chelation to the elimination of monocytes to the “old favourites” of IVM and HCQ, pus maybe this one  I mentioned a few days ago that is intriguing.

Russian paper:

Self-assembling amyloid-like nanostructures from SARS-CoV-2 S1, S2, RBD and N recombinant proteins - ScienceDirect

“An ultrathin nanosheets were fabricated from copper indium thiophosphate (CuInP2S 6, denoted CIPS) for anti-SARS-CoV-2 therapy, as a decontamination agent and surface-coating material to reduce SARS-CoV-2 infectivity.

CIPS exhibits high and selective binding capacity (dissociation constant (KD) < 1 pM) for the SARS-CoV-2 spike protein RBD domain, inhibiting virus entry and infection in angiotensin converting enzyme 2 (ACE2)-bearing cells, human airway epithelial organoids and human ACE2-transgenic mice.

On association with CIPS, the virus is quickly phagocytosed and eliminated by macrophages, suggesting that CIPS could be successfully used to capture and facilitate virus elimination by the host [29].”

Sort of a Russian version of IVM?

Onwards!

Please subscribe or donate via Ko-fi – any amount from 3 bucks upwards. Don’t worry and God Bless, if you can’t or don’t want to. Ko-fi donations here: https://ko-fi.com/peterhalligan - an annual subscription of 100 bucks is one third less than a $3 Ko-fi donation a week!